High-Dose Treatment With Telmisartan Induces Monocytic Peroxisome Proliferator-Activated Receptor-gamma Target Genes in Patients With the Metabolic Syndrome
Hypertension, 09/09/2011
Clinical Article
Bähr IN et al. – This is the first clinical description of monocytic peroxisome proliferator–activated receptor–gamma (PPAR–gamma) target gene regulation with high–dose telmisartan treatment. These data implicate that the angiotensin type 1 receptor blocker telmisartan activates PPAR–gamma in circulating monocytes of patients with the metabolic syndrome







